SinoPep: difference between revisions
Diff·revision 26 → 27·07:10, 25 Feb 2026
Difference between revision 26 and revision 27 of SinoPep. 8 lines changed; the page grew by 1,342 bytes.
| Revision 26 — 08:18, 11 Feb 2026 ShortageShona (talk) add the research-use-only statement to the lead rather than only the footer 16,798 bytes ±0 | Revision 27 — 07:10, 25 Feb 2026 BlankVialBo (talk) state which lines are held in regional stock 18,140 bytes +1,342 | ||
|---|---|---|---|
| 103 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | 103 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} |
| 104 | 104 | ||
| + | 105 | Two frameworks are named in this article only to say what has ''not'' been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,{{r|gmp}} and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.{{r|iso17025}} Neither assessment is available here for this organisation or for any other covered on this wiki. | |
| + | 106 | ||
| + | 107 | == External links == | |
| + | 108 | * [https://sinopep.net/ SinoPep Biotechnology (Changzhou) Co., Ltd. — official site (sinopep.net)] — the organisation's own catalogue, stock listing and ordering pages. Marked <code>nofollow</code> and <code>sponsored</code>; PeptidePedia takes no commission and the link is not an endorsement. | |
| + | 109 | * [[Project:Vendor notability]] — why this article carries an outbound link and the organisations listed at the foot of [[Category:Peptide suppliers]] do not. | |
| + | 110 | ||
| 105 | == References == | 111 | == References == |
| 106 | {{reflist}} | 112 | {{reflist}} |
| ⋮ | ⋮ | ||
| 110 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 116 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 111 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 117 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| + | 118 | <ref name="iso17025">ISO/IEC 17025:2017, ''General requirements for the competence of testing and calibration laboratories''. International Organization for Standardization.</ref> | |
| 112 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 119 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 120 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 113 | 121 | ||
| 114 | == Further reading == | 122 | == Further reading == |